RBM, SMAF Discover Candidate Biomarkers for Spinal Muscular Atrophy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rules-Based Medicine and the Spinal Muscular Atrophy Foundation today announced the discovery of candidate biomarkers, the first milestone in a program by the parties to develop a panel of protein biomarkers using RBM technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.